This inventor holds 2 USPTO granted patents. Top assignee: Adaptive Biotechnologies Corporation. Active years: 2022-2026.
Company Filing History:
Years Active: 2022-2026
Title: Innovator Marcos E Milla: Pioneering T Cell Receptor Technology
Introduction
Marcos E Milla is an accomplished inventor based in Seattle, WA. He has made significant contributions to the field of immunology, particularly in the development of methods for determining antigen-specific T cells. His work is crucial for advancing cancer therapies and understanding immune responses.
Latest Patents
Marcos E Milla holds a patent for "Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)." This invention focuses on methods for identifying antigen-specific T cells and T cell receptors that bind to the Wilms' tumor antigen-1 (WT1) protein. The patent also includes polynucleotides encoding the TCRs, engineered cells that express these TCRs, and methods for their production and application. He has 1 patent to his name.
Career Highlights
Marcos E Milla is associated with Adaptive Biotechnologies Corporation, a company known for its innovative approaches in the field of biotechnology. His work at the company has positioned him as a key player in the development of T cell receptor technologies.
Collaborations
Marcos has collaborated with notable colleagues, including Edward J Osborne and Joyce K Hu. These partnerships have further enhanced the research and development efforts in the field of T cell therapies.
Conclusion
Marcos E Milla's contributions to T cell receptor technology represent a significant advancement in immunology. His innovative work continues to pave the way for new therapeutic strategies in cancer treatment.